OncoGynecology Xagena
Aggiornamento in Medicina
The results of a phase III study ( Study 301 ) of Eribulin mesylate ( Halaven ) versus Capecitabine ( Xeloda ) in locally advanced or metastatic breast cancer were presented at the 2012 CTRC-AACR San ...